MetLife, Inc. $MET Shares Sold by Callan Family Office LLC

Callan Family Office LLC lessened its stake in shares of MetLife, Inc. (NYSE:MET) by 7.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 130,604 shares of the financial services provider’s stock after selling 10,542 shares during the quarter. Callan Family Office LLC’s holdings in MetLife were worth $10,758,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in MET. Quaker Wealth Management LLC grew its holdings in shares of MetLife by 198.2% during the second quarter. Quaker Wealth Management LLC now owns 333 shares of the financial services provider’s stock worth $27,000 after buying an additional 672 shares in the last quarter. Evolution Wealth Management Inc. acquired a new position in MetLife in the 2nd quarter valued at $35,000. Salomon & Ludwin LLC lifted its stake in shares of MetLife by 95.4% during the 3rd quarter. Salomon & Ludwin LLC now owns 422 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 206 shares during the period. True Wealth Design LLC boosted its holdings in shares of MetLife by 564.1% during the third quarter. True Wealth Design LLC now owns 425 shares of the financial services provider’s stock worth $35,000 after purchasing an additional 361 shares during the last quarter. Finally, MTM Investment Management LLC purchased a new stake in shares of MetLife in the second quarter valued at $37,000. 94.99% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on MET. UBS Group reduced their target price on MetLife from $95.00 to $94.00 and set a “buy” rating on the stock in a research report on Thursday, January 8th. Morgan Stanley set a $101.00 price objective on shares of MetLife and gave the stock an “overweight” rating in a report on Monday, December 15th. Keefe, Bruyette & Woods lowered their target price on shares of MetLife from $92.00 to $90.00 and set an “outperform” rating for the company in a report on Tuesday, November 11th. Wells Fargo & Company increased their price target on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. Finally, Barclays set a $90.00 price objective on MetLife in a report on Thursday, January 8th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $95.27.

MetLife Price Performance

Shares of NYSE MET opened at $79.86 on Tuesday. The company has a market capitalization of $52.62 billion, a price-to-earnings ratio of 15.04, a PEG ratio of 0.75 and a beta of 0.76. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.18 and a quick ratio of 0.18. MetLife, Inc. has a 1-year low of $65.21 and a 1-year high of $87.39. The business has a 50-day moving average of $78.86 and a 200-day moving average of $78.84.

MetLife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 5th. The financial services provider reported $2.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.30 by $0.07. MetLife had a net margin of 5.30% and a return on equity of 21.00%. The company had revenue of $12.46 billion during the quarter, compared to the consensus estimate of $18.64 billion. During the same quarter last year, the company earned $1.95 earnings per share. MetLife’s revenue for the quarter was down 5.9% on a year-over-year basis. On average, equities analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 10th. Shareholders of record on Tuesday, February 3rd will be given a $0.5675 dividend. This represents a $2.27 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend is Tuesday, February 3rd. MetLife’s dividend payout ratio is presently 42.75%.

MetLife Profile

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.